These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Inhibition of the 26S proteasome by peptide mimics of the coiled-coil region of its ATPase subunits. Inobe T; Genmei R Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):143-50. PubMed ID: 26522225 [TBL] [Abstract][Full Text] [Related]
23. Inhibitors of the eukaryotic 20S proteasome core particle: a structural approach. Groll M; Huber R Biochim Biophys Acta; 2004 Nov; 1695(1-3):33-44. PubMed ID: 15571807 [TBL] [Abstract][Full Text] [Related]
24. Osirisynes G-I, New Long-Chain Highly Oxygenated Polyacetylenes from the Mayotte Marine Sponge Campos PE; Herbette G; Chendo C; Clerc P; Tintillier F; de Voogd NJ; Papanagnou ED; Trougakos IP; Jerabek M; Bignon J; Le Goff G; Ouazzani J; Gauvin-Bialecki A Mar Drugs; 2020 Jul; 18(7):. PubMed ID: 32635268 [TBL] [Abstract][Full Text] [Related]
25. Mixing of peptides and electrophilic traps gives rise to potent, broad-spectrum proteasome inhibitors. Verdoes M; Florea BI; van der Linden WA; Renou D; van den Nieuwendijk AM; van der Marel GA; Overkleeft HS Org Biomol Chem; 2007 May; 5(9):1416-26. PubMed ID: 17464411 [TBL] [Abstract][Full Text] [Related]
26. Mechanistic insights on petrosaspongiolide M inhibitory effects on immunoproteasome and autophagy. Monti MC; Margarucci L; Riccio R; Bonfili L; Mozzicafreddo M; Eleuteri AM; Casapullo A Biochim Biophys Acta; 2014 Apr; 1844(4):713-21. PubMed ID: 24530967 [TBL] [Abstract][Full Text] [Related]
27. EnT-Mediated N-S Bond Homolysis of a Bifunctional Reagent Leading to Aliphatic Sulfonyl Fluorides. Erchinger JE; Hoogesteger R; Laskar R; Dutta S; Hümpel C; Rana D; Daniliuc CG; Glorius F J Am Chem Soc; 2023 Feb; 145(4):2364-2374. PubMed ID: 36652725 [TBL] [Abstract][Full Text] [Related]
28. Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges. Patel DN; Li L; Kee CL; Ge X; Low MY; Koh HL J Pharm Biomed Anal; 2014 Jan; 87():176-90. PubMed ID: 23721687 [TBL] [Abstract][Full Text] [Related]
30. Discovery of novel covalent proteasome inhibitors through a combination of pharmacophore screening, covalent docking, and molecular dynamics simulations. Li A; Sun H; Du L; Wu X; Cao J; You Q; Li Y J Mol Model; 2014 Nov; 20(11):2515. PubMed ID: 25394401 [TBL] [Abstract][Full Text] [Related]
31. An Investigation into the In Vitro Metabolic Stability of Aryl Sulfonyl Fluorides for their Application in Medicinal Chemistry and Radiochemistry. King AT; Matesic L; Keaveney ST; Jamie JF Mol Pharm; 2023 Feb; 20(2):1061-1071. PubMed ID: 36638322 [TBL] [Abstract][Full Text] [Related]
32. Structurally novel highly potent proteasome inhibitors created by the structure-based hybridization of nonpeptidic belactosin derivatives and peptide boronates. Kawamura S; Unno Y; Asai A; Arisawa M; Shuto S J Med Chem; 2014 Mar; 57(6):2726-35. PubMed ID: 24524217 [TBL] [Abstract][Full Text] [Related]
33. Proteasome inhibition correlates with intracellular bortezomib concentrations but not with antiproliferative effects after bolus treatment in myeloma cell lines. Dettmer S; Theile D; Schäfer J; Seckinger A; Burhenne J; Weiss J Naunyn Schmiedebergs Arch Pharmacol; 2016 Oct; 389(10):1091-101. PubMed ID: 27422413 [TBL] [Abstract][Full Text] [Related]
34. Identification of noncovalent proteasome inhibitors with high selectivity for chymotrypsin-like activity by a multistep structure-based virtual screening. Di Giovanni C; Ettari R; Sarno S; Rotondo A; Bitto A; Squadrito F; Altavilla D; Schirmeister T; Novellino E; Grasso S; Zappalà M; Lavecchia A Eur J Med Chem; 2016 Oct; 121():578-591. PubMed ID: 27318981 [TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological properties of C-terminal vinyl ketone pseudotripeptides. Franceschini C; Trapella C; Sforza F; Gavioli R; Marastoni M J Enzyme Inhib Med Chem; 2013 Jun; 28(3):560-4. PubMed ID: 22380778 [TBL] [Abstract][Full Text] [Related]
36. Synthesis and activity of isoxazoline vinyl ester pseudopeptides as proteasome inhibitors. Marastoni M; Scotti A; Trapella C; Ferretti V; Sforza F; Gavioli R J Pept Sci; 2014 Apr; 20(4):258-65. PubMed ID: 24677765 [TBL] [Abstract][Full Text] [Related]
37. Synthesis of Quinoline Silyloxymethylsulfones as Intermediates to Sulfonyl Derivatives. Patel TI; Laha R; Moschitto MJ J Org Chem; 2022 Nov; 87(22):15679-15683. PubMed ID: 36305839 [TBL] [Abstract][Full Text] [Related]
38. Potent proteasome inhibitors derived from the unnatural cis-cyclopropane isomer of Belactosin A: synthesis, biological activity, and mode of action. Kawamura S; Unno Y; List A; Mizuno A; Tanaka M; Sasaki T; Arisawa M; Asai A; Groll M; Shuto S J Med Chem; 2013 May; 56(9):3689-700. PubMed ID: 23547757 [TBL] [Abstract][Full Text] [Related]
39. Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor. Deutsch DG; Lin S; Hill WA; Morse KL; Salehani D; Arreaza G; Omeir RL; Makriyannis A Biochem Biophys Res Commun; 1997 Feb; 231(1):217-21. PubMed ID: 9070252 [TBL] [Abstract][Full Text] [Related]
40. Pharmacophore modeling technique applied for the discovery of proteasome inhibitors. Pautasso C; Troia R; Genuardi M; Palumbo A Expert Opin Drug Discov; 2014 Aug; 9(8):931-43. PubMed ID: 24877566 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]